-
Announcing our research partnership investment with CRUK
Scottish scientist set to receive over £6 million from Cancer Research UK and The Brain Tumour Charity to find new ways to treat glioblastoma, one of the hardest types of cancer to treat.
-
The response to our joint cancer charity letter to the Department of Health
In February, we co-signed a joint letter with other cancer charities to the Secretary of State for Health and Social Care which outlined concerns regarding cancer research in the UK post Brexit
-
Three things from NHS England’s interim workforce plan
Earlier this month, NHS England released their ‘Interim NHS People’s Plan’ detailing what measures will be implemented in and ahead of their full workforce proposal
-
Announcing our new £3.7m global research investment
Thanks to the support of our community, we’re pledging more than £3.7m to UK and international teams working towards our twin goals: doubling brain tumour survival and halving the harm caused by the disease
-
Top exam tips
Most people find exams stressful and it’s safe to say that living with a brain tumour doesn’t make them any easier! Kaleb Ells, a member of our young adults community, has shared some of his top tips for getting through exam season.
-
Tocagen’s ‘breakthrough’ gene therapy trial will continue
After undergoing an interim analysis, a phase 3 clinical trial called Toca 5 that tests a gene therapy in patients with recurrent brain cancer, will continue
-
Data access vital for NHS digital revolution
The Health Secretary, Matt Hancock, has spoken today of his frustration at slow progress towards embracing digital technology in the NHS.
-
Launching The Twilight Walk 2019
Side by side, stride by stride, let’s pick up the pace of progress
-
Analysis shows Deputax-M is unsuccessful
Deputax-M failed to meet its target overall survival during an interim analysis of a phase 3 clinical trial in glioblastoma
-
Nivolumab fails to meet its target
Nivolumab, an immunotherapy drug, has been unsuccessful in improving overall survival in a phase 3 clinical trial when tested in newly diagnosed glioblastoma with unmethylated MGMT
-
Telling your loved ones about your brain tumour diagnosis
Chartered Clinical Psychologist, Dr Nick Mooney, offers advice on how best to start talking with your family and friends about brain tumours.
-
Redefining medulloblastoma
New research from one of our funded grants gives much needed insight into group 3 and 4 medulloblastoma
-
5-ALA the ‘Pink Drink’ – What you need to know
There have been a number of headlines over the last two days about a ‘new treatment’ that may save thousands of lives for brain tumour patients
-
New treatments for diffuse midline gliomas
A new type of drug that targets a particular protein could become the first ever treatment designed for children with diffuse midline gliomas (formerly known as DIPG)
-
Top tips to care for your mental health
In preparation for Mental Health Awareness Week 2019, we’ve pulled together six top tips for looking after your mental health that are perfect for anybody affected by a brain tumour.
-
Remembering Tessa Jowell, one year on
This weekend marks a year since Tessa Jowell died from a brain tumour
-
The Charity holds the first ever brain tumour roundtable in Wales
The Brain Tumour Charity held the first ever roundtable on brain tumours in Wales, bringing together a wide range of stakeholders within the brain tumour community to discuss what needs to be achieved to improve patient outcomes in Wales.
-
Pencil-beam scanning proton therapy could spare memory and cognitive function in children
Research presented recently at a conference in Milan showed that a particular type of radiation therapy could help spare children’s memory and thinking when they undergo treatment for brain tumours
-
Why Deliciously Ella’s Matt Mills is running the London Marathon
Matt is the son of Baroness Tessa Jowell, who galvanised the political community in the House of Lords with her campaign for those affected by brain tumours following her own diagnosis
-
Using artificial intelligence to assess the treatment response of brain tumours
A research team from Germany has used artificial intelligence to improve the assessment of treatment response in brain tumours
-
Be part of the NHS Personal Health Budget survey
NHS England are currently running a questionnaire to find out more about people’s experiences of Personal Health Budgets, which could feed into and shape the future of personalised healthcare
-
The London Marathon: a personal blog
The Charity’s corporate partnerships officer Steve Salazar, has been pounding the training miles
-
Revising for and sitting exams when living with a brain tumour
Exams are challenging at the best of times. But if you’re living with a brain tumour, you’re also likely to be struggling with fatigue, concentration or memory problems, making them even more difficult.
-
Speech and Cognition problems: Oliver’s Story
Oliver Highway was first diagnosed with a brain tumour in April 2012, aged just 39. As a result of his tumour and its treatment, Oliver’s life was turned upside-down when he was left with speech and cognition problems. But with the help of his family, Oliver hasn’t let these side-effects hold him back.